Durvalumab vs Rivaroxaban

Durvalumab vs Rivaroxaban: Overview

This comparison examines the pharmacological differences between Durvalumab and Rivaroxaban.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Rivaroxaban: Direct Factor Xa inhibitor.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Rivaroxaban — 5-9 hours.

Chemical Properties

Molecular Formula: Rivaroxaban — C19H18ClN3O5S.

Molecular Weight: Rivaroxaban — 435.8820 g/mol.

Type: Durvalumab — Antibody; Rivaroxaban — Small molecule.